Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C43H58N2O13 |
Molecular Weight | 810.9262 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)C(=O)COC1=C2C3=C4O[C@](C)(O\C=C\[C@H](OC)[C@@H](C)[C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)C(=O)NC(=C1)C(O)=C2C(O)=C4C)C3=O
InChI
InChIKey=VFYNXKZVOUXHDX-VDPUEHCXSA-N
InChI=1S/C43H58N2O13/c1-12-45(13-2)31(47)20-55-30-19-28-38(51)33-32(30)34-40(26(8)37(33)50)58-43(10,41(34)52)56-18-17-29(54-11)23(5)39(57-27(9)46)25(7)36(49)24(6)35(48)21(3)15-14-16-22(4)42(53)44-28/h14-19,21,23-25,29,35-36,39,48-51H,12-13,20H2,1-11H3,(H,44,53)/b15-14+,18-17+,22-16-/t21-,23+,24+,25+,29-,35-,36+,39+,43-/m0/s1
Rifamides (NSC-143418) are drugs used in the treatment of tuberculosis. They also have immunosuppressive activity, the exact mechanism of which is still unknown, although the ability of rifamides to inhibit tumor necrosis factor (TNF)-induced NF-kB activation may be associated with it. A variety of rifamide analogues exist, such as rifamycin B, rifapentine, rifamycin SV, rifabutin and rifampicin.
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C258
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C152215
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
SUB10308MIG
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
m9610
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
2750-76-7
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
C009186
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
CHEMBL2103908
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
1952
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
100000080580
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
143418
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
DTXSID901023450
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
133099
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
220-390-8
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
TS121H7U7E
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY | |||
|
6433345
Created by
admin on Fri Dec 15 16:53:28 GMT 2023 , Edited by admin on Fri Dec 15 16:53:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY